Disruption of pathologic amyloid β-protein fibril assembly on the surface of cultured human cerebrovascular smooth muscle cells

Amyloid

Volumn 8, Issue SUPPL. 1, 2001, Pages 20-27

  Van Nostrand, W E ^a   Melchor, J P ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

Amyloid protein; Cerebrovascular smooth muscle cells; Fibrils

Indexed keywords

AMYLOID BETA PROTEIN; THIOFLAVINE;

ALZHEIMER DISEASE; APOPTOSIS; BRAIN BLOOD VESSEL; CELL CULTURE; CELL SURFACE; CONFERENCE PAPER; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN EXPRESSION; SMOOTH MUSCLE FIBER; VASCULAR AMYLOIDOSIS;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; BRAIN; CELL MEMBRANE; CELLS, CULTURED; CEREBRAL AMYLOID ANGIOPATHY; HUMANS; INOSITOL; MACROMOLECULAR SUBSTANCES; MELATONIN; MICROSCOPY, ELECTRON; MUSCLE, SMOOTH, VASCULAR; RIFAMPIN; ROLITETRACYCLINE;

EID: 0034837670     PISSN: 13506129     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (28)

1. Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein
2. Cerebral amyloid angiopathy in the brains of patients with Alzheimer's disease: The CERAD experience, Part XV
3. Hereditary cerebral haemorrhage with amyloidosis, Dutch type (HCHWA-D): Clinicopathological studies
4. Translating cell biology into therapeutic advances in Alzheimer's disease
5. Degeneration of smooth muscle cells in beta-amyloid angiopathies
6. Degeneration of vascular muscle cells in cerebral amyloid angiopathy of Alzheimer disease
7. Vascular β-amyloid in Alzheimer's disease angiopathy is produced by proliferating and degenerating smooth muscle cells
8. Alzheimer's amyloid β-protein induces its own production in cultured cerebrovascular smooth muscle cells
9. Aggregation of amyloid β-protein nullifies its pathologic properties in cultured cerebrovascular smooth muscle cells
10. Amyloid β-protein induces the cerebrovascular cellular pathology of Alzheimer's disease and related disorders
11. Enhanced pathologic properties of Dutch-type mutant amyloid β-protein
12. Charge alterations of E22 in the amyloid β-protein enhance its pathogenic properties
13. Pathologic cell surface amyloid β-protein fibril assembly in cultured human cerebrovascular smooth muscle cells
14. Inhibition of Alzheimer β-fibillogenesis by melatonin
15. Inhibition of amyloid β protein aggregation and neurotoxicity by rifampicin
16. Common structural features determine the effectiveness of carvedilol, daunomycin, and rolitetracycline as inhibitors of Alzheimer 13-amyloid fibril formation
17. Arrest of β-amyloid fibril formation by pentapeptide ligand
18. Phosphatidylinositol and inositol involvement in Alzheimer amyloid β fibril growth and arrest
19. Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red
20. Assembly and aggregation properties of synthetic Alzheimer's A4/β amyloid peptide analogs
21. Amyloid β-protein precursor in cultured leptomeningeal smooth muscle cells
22. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye-binding
23. Protease nexin-II, a potent antichymotrypsin, shows identity to the amyloid β-protein precursor
24. Pathogenic amyloid β-protein induces apoptosis in cultured human cerebrovascular smooth muscle cells
25. Fibrillar amyloid β-protein mediates the pathologic accumulation of its secreted precursor in human cerebrovascular smooth muscle cells
26. In vitro aging of β-amyloid protein causes peptide aggregation and neurotoxicity
27. Neurodegeneration induced by β-amyloid peptides in vitro: The role of peptide assembly state
28. Amyloid β interacts with amyloid precursor protein: A potential toxic mechanism in Alzheimer's disease